The store will not work correctly when cookies are disabled.
(RR/SS)-2-[1-(4-isopropylphenyl)-3-methylbutyl]piperidine
ID: ALA218193
PubChem CID: 16102769
Max Phase: Preclinical
Molecular Formula: C19H31N
Molecular Weight: 273.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)CC(c1ccc(C(C)C)cc1)C1CCCCN1
Standard InChI: InChI=1S/C19H31N/c1-14(2)13-18(19-7-5-6-12-20-19)17-10-8-16(9-11-17)15(3)4/h8-11,14-15,18-20H,5-7,12-13H2,1-4H3
Standard InChI Key: OYPZJIHQZRPSNC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
10.1281 -7.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8471 -6.7650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5631 -7.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2813 -6.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2829 -5.9391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5604 -5.5217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8450 -5.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4152 -6.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4189 -5.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7101 -5.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9925 -5.9284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9883 -6.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1254 -8.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7001 -7.1715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8382 -8.4155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8354 -9.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5536 -8.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9975 -5.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7112 -5.9406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9984 -4.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
5 6 1 0
8 14 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 14 1 0
1 2 1 0
1 13 1 0
6 7 2 0
7 2 1 0
13 15 1 0
3 4 1 0
15 16 1 0
1 8 1 0
15 17 1 0
8 9 1 0
5 18 1 0
18 19 1 0
4 5 2 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.46 | Molecular Weight (Monoisotopic): 273.2456 | AlogP: 5.08 | #Rotatable Bonds: 5 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 5.52 | CX LogD: 2.76 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: 0.38 |
References
1. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |
2. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |